Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair

The purpose of the investigation is to determine whether Atrovastatin as anti-inflammatory agent can be effective in preventing from atrial fibrillation incidence in patients whom undergone open cardiac surgery for their heart valve repair.

Inclusion Criteria:

• Greater than 25 y/o
• No occurrence of intra- or post-operative cardiopulmonary arrest
• Not consuming drugs affecting atrial rhythm
• Having sinus rhythm before surgery
• Lack of paroxysmal atrial fibrillation history
• Only undergo heart valve surgery
• Lack of considerable heart ischemia needed atorvastatin use
• Routine cares in ward, post-operative ward, and intensive care unit were done

Exclusion Criteria:

• Lesser than 25 y/o
• History of atrial fibrillation
• History of taking anti-arrhythmic drugs
• History of implementing pacemakers
• Severe heart failure
• Renal failure
• Hepatic failure
• Severe pulmonary diseases
• Heart block or bradyarrhythmia
• Routine cares in ward, post-operative ward, and intensive care unit were not done
• Performing concomitant cardiac surgery except valve repair
• Having considerable heart ischemia needed atorvastatin use